248 related articles for article (PubMed ID: 28899762)
21. Structure and function of the blood-brain barrier.
Abbott NJ; Patabendige AA; Dolman DE; Yusof SR; Begley DJ
Neurobiol Dis; 2010 Jan; 37(1):13-25. PubMed ID: 19664713
[TBL] [Abstract][Full Text] [Related]
22. Transcellular Model for Neutral and Charged Nanoparticles Across an In Vitro Blood-Brain Barrier.
Zhang L; Fan J; Li G; Yin Z; Fu BM
Cardiovasc Eng Technol; 2020 Dec; 11(6):607-620. PubMed ID: 33113565
[TBL] [Abstract][Full Text] [Related]
23. Nano-enabled delivery systems across the blood-brain barrier.
Hwang SR; Kim K
Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511
[TBL] [Abstract][Full Text] [Related]
24. Blood brain barrier: An overview on strategies in drug delivery, realistic in vitro modeling and in vivo live tracking.
Pandey PK; Sharma AK; Gupta U
Tissue Barriers; 2016; 4(1):e1129476. PubMed ID: 27141418
[TBL] [Abstract][Full Text] [Related]
25. Mustard-inspired delivery shuttle for enhanced blood-brain barrier penetration and effective drug delivery in glioma therapy.
Wang N; Sun P; Lv M; Tong G; Jin X; Zhu X
Biomater Sci; 2017 May; 5(5):1041-1050. PubMed ID: 28378865
[TBL] [Abstract][Full Text] [Related]
26. Accessing targeted nanoparticles to the brain: the vascular route.
Burkhart A; Azizi M; Thomsen MS; Thomsen LB; Moos T
Curr Med Chem; 2014; 21(36):4092-9. PubMed ID: 25039779
[TBL] [Abstract][Full Text] [Related]
27. Optimal nanoparticle design for effective transport through the blood-brain barrier.
Park K
J Control Release; 2019 Feb; 295():290. PubMed ID: 30704674
[No Abstract] [Full Text] [Related]
28. Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models.
Hellinger E; Veszelka S; Tóth AE; Walter F; Kittel A; Bakk ML; Tihanyi K; Háda V; Nakagawa S; Duy TD; Niwa M; Deli MA; Vastag M
Eur J Pharm Biopharm; 2012 Oct; 82(2):340-51. PubMed ID: 22906709
[TBL] [Abstract][Full Text] [Related]
29. Strategies to overcome the barrier: use of nanoparticles as carriers and modulators of barrier properties.
Rempe R; Cramer S; Qiao R; Galla HJ
Cell Tissue Res; 2014 Mar; 355(3):717-26. PubMed ID: 24585360
[TBL] [Abstract][Full Text] [Related]
30. Functional morphology of the blood-brain barrier in health and disease.
Liebner S; Dijkhuizen RM; Reiss Y; Plate KH; Agalliu D; Constantin G
Acta Neuropathol; 2018 Mar; 135(3):311-336. PubMed ID: 29411111
[TBL] [Abstract][Full Text] [Related]
31. Drug delivery to the CNS and polymeric nanoparticulate carriers.
Costantino L
Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
[TBL] [Abstract][Full Text] [Related]
32. Crossing the blood-brain barrier with nanoparticles.
Zhou Y; Peng Z; Seven ES; Leblanc RM
J Control Release; 2018 Jan; 270():290-303. PubMed ID: 29269142
[TBL] [Abstract][Full Text] [Related]
33. Maintaining blood-brain barrier integrity: pericytes perform better than astrocytes during prolonged oxygen deprivation.
Al Ahmad A; Gassmann M; Ogunshola OO
J Cell Physiol; 2009 Mar; 218(3):612-22. PubMed ID: 19016245
[TBL] [Abstract][Full Text] [Related]
34. Tight junction modulation of the blood brain barrier: CNS delivery of small molecules.
Greene C; Campbell M
Tissue Barriers; 2016; 4(1):e1138017. PubMed ID: 27141420
[TBL] [Abstract][Full Text] [Related]
35. Adenosine receptor signaling: a key to opening the blood-brain door.
Bynoe MS; Viret C; Yan A; Kim DG
Fluids Barriers CNS; 2015 Sep; 12():20. PubMed ID: 26330053
[TBL] [Abstract][Full Text] [Related]
36. Lipid-based nanocarrier efficiently delivers highly water soluble drug across the blood-brain barrier into brain.
Dutta L; Mukherjee B; Chakraborty T; Das MK; Mondal L; Bhattacharya S; Gaonkar RH; Debnath MC
Drug Deliv; 2018 Nov; 25(1):504-516. PubMed ID: 29426257
[TBL] [Abstract][Full Text] [Related]
37. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.
Tang W; Fan W; Lau J; Deng L; Shen Z; Chen X
Chem Soc Rev; 2019 Jun; 48(11):2967-3014. PubMed ID: 31089607
[TBL] [Abstract][Full Text] [Related]
38. Nanoparticles as a Carrier System for Drug Delivery Across Blood Brain Barrier.
Sarkar A; Fatima I; Jamal QMS; Sayeed U; Khan MKA; Akhtar S; Kamal MA; Farooqui A; Siddiqui MH
Curr Drug Metab; 2017; 18(2):129-137. PubMed ID: 28088890
[TBL] [Abstract][Full Text] [Related]
39. Nanotech revolution for the anti-cancer drug delivery through blood-brain barrier.
Caraglia M; De Rosa G; Salzano G; Santini D; Lamberti M; Sperlongano P; Lombardi A; Abbruzzese A; Addeo R
Curr Cancer Drug Targets; 2012 Mar; 12(3):186-96. PubMed ID: 22268384
[TBL] [Abstract][Full Text] [Related]
40. Solid lipid nanoparticles carrying chemotherapeutic drug across the blood-brain barrier through insulin receptor-mediated pathway.
Kuo YC; Shih-Huang CY
J Drug Target; 2013 Sep; 21(8):730-8. PubMed ID: 23815407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
